Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CNS Pharmaceuticals Q4 EPS $(1.58) Beats $(6.00) Estimate

Author: Benzinga Newsdesk | May 16, 2025 08:19am
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(6.00) by 73.67 percent. This is a 99.85 percent increase over losses of $(1.02 thousand) per share from the same period last year.

Posted In: CNSP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist